-
1Academic Journal
Συγγραφείς: M. C. Weinstein, George Torrance, Alistair Mcguire, I. A. Vilum, S. L. Plavinskii, D. Yu. Belousov
Πηγή: Качественная клиническая практика, Vol 0, Iss 2, Pp 70-78 (2018)
Θεματικοί όροι: откорректированная по качеству продолжительность жизни, анализ стоимости-эффективности, предпочтения, полезность, метод стандартной азартной игры, метод временной эквивалентности, типология, теория, quality-adjusted life-year, cost-effectiveness analysis, preference, utility, standard gamble, time trade-off, taxonomy, theory, qaly, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441
Περιγραφή αρχείου: electronic resource
Relation: https://www.clinvest.ru/jour/article/view/17; https://doaj.org/toc/2588-0519; https://doaj.org/toc/2618-8473
Σύνδεσμος πρόσβασης: https://doaj.org/article/02d7191a648a46c9922fb92615025bac
-
2Academic Journal
Συγγραφείς: Paul Kind, Jennifer Elston Lafata, Karl Matuszewski, Dennis Raisch, I. A. Vilum, A. S. Kolbin
Πηγή: Качественная клиническая практика, Vol 0, Iss 2, Pp 92-97 (2018)
Θεματικοί όροι: принятие решений на уровне пациента, откорректированная по качеству продолжительность жизни, экономический анализ, patient decision-making, qaly, economic analysis, cost-utility analysis, анализ затраты-полезность, Medical technology, R855-855.5, Pharmacy and materia medica, RS1-441
Περιγραφή αρχείου: electronic resource
Relation: https://www.clinvest.ru/jour/article/view/19; https://doaj.org/toc/2588-0519; https://doaj.org/toc/2618-8473
Σύνδεσμος πρόσβασης: https://doaj.org/article/5d3124dadc4c4ed98b48830f6f1057bd
-
3Academic Journal
Συγγραφείς: Paul Kind, Jennifer Elston Lafata, Karl Matuszewski, Dennis Raisch, I. A. Vilum, A. S. Kolbin, И. А. Вилюм, А. С. Колбин
Πηγή: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice; № 2 (2015); 92-97 ; Качественная клиническая практика; № 2 (2015); 92-97 ; 2618-8473 ; 2588-0519
Θεματικοί όροι: анализ затраты-полезность, откорректированная по качеству продолжительность жизни, экономический анализ, patient decision-making, QALY, economic analysis, cost-utility analysis
Περιγραφή αρχείου: application/pdf
Relation: https://www.clinvest.ru/jour/article/view/19/19; American College of Physicians. Information on cost- effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med 2008;148:956-61.; Aspinall S.L., Good C.B., Glassman P.A., Valentino M.A. The evolv- ing use of cost-effectiveness analysis in formulary management within the Department of Veterans Affairs. Med Care 2005;43: 20-6.; Parameswaran R., McNair A., Avery K.N., et al. The role of health- related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 2008;15:2372-9.; Halyard M.Y., Ferrans C.E. Quality-of-life assessment for routine oncology clinical practice. J Support Oncol 2008;6:221-33.; Alishiri G.H., Bayat N., Fathi Ashtiani A., et al. Logistic regres- sion models for predicting physical and mental health-related quality of life in rheumatoid arthritis patients. Mod Rheumatol in press.; Kolotkin R.L., Crosby R.D., Gress R.E., et al. Health and health-related quality of life: differences between men and women who seek gastric bypass surgery. Surg Obes Relat Dis 2008;4: 651-8.; Efficace F., Kemmler G., Vignetti M., et al. Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials-a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 2008;44: 1497-506.; Weinfurt KP. Outcomes research related to patient decision making in oncology. Clin Ther 2003;25:671-83.; Kaplan R.M. Shared medical decision-making: a new paradigm for behavioral medicine-1997 presidential address. Ann Behav Med 1999;21:3-11.; Eiser C., Darlington A.S., Stride C.B., Grimer R. Quality of life implications as a consequence of surgery: limb salvage, primary and secondary amputation. Sarcoma 2001;5:189-95.; de Haes H, Koedoot N. Patient centered decision making in palliative cancer treatment: a world of paradoxes. Patient Educ Couns 2003;50:43-9.; Solomon M.J., Pager C.K., Keshava A., et al. What do patients want? Patient preferences and surrogate decision making in the treat- ment of colorectal cancer. Dis Colon Rectum 2003;46: 1351-7.; Protiere C., Viens P., Genre D., et al. Patient participation in medical decision-making: a French study in adjuvant radio- chemotherapy for early breast cancer. Ann Oncol 2000;11:39- 45.; Schackman B.R., Teixeira P.A., Weitzman G., et al. Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree? Med Decis Making 2008;28:233-42.; Goodlin S.J., Quill T.E., Arnold R.M. Communication and decision- making about prognosis in heart failure care. J Card Fail 2008;14:106-13.; Pruchno R.A., Lemay E.P. Jr, Field L., Levinsky N.G. Predictors of patient treatment preferences and spouse substituted judgments: the case of dialysis continuation. Med Decis Making 2006;26: 112-21.; Grosset K.A., Grosset D.G. Patient-perceived involvement and sat- isfaction in Parkinson’s disease: effect on therapy decisions and quality of life. Mov Disord 2005;20:616-9.; Hankins J., Hinds P., Day S., et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer 2007;48:705-10.; Sullivan M.D., Levy W.C., Russo J.E., et al. Summary health status measures in advanced heart failure: relationship to clinical vari- ables and outcome. J Card Fail 2007;13:560-8.; Glasziou P., Alexander J., Beller E., Clarke P. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. Health Qual Life Outcomes 2007;5:21.; Watkins J.B., Minshall M.E., Sullivan S.D. Application of economic analyses in U.S. managed care formulary decisions: a private payer’s experience. J Manag Care Pharm 2006;12:726-35.; Schmittdiel J., Vijan S., Fireman B., et al. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Med Care 2007;45:315-21.; Department of Health. Guidance on the routine collection of Patient Reported Outcome Measures (PROMs). Available from: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_091451 [Accessed Decem- ber 12, 2008].; Prochaska J.M., Prochaska J.O., Levesque D.A. A transtheoretical approach to changing organizations. Adm Policy Ment Health 2001;28:247-61.; Prochaska J.O., Velicer W.F. The transtheoretical model of health behavior change. Am J Health Promot 1997;12:38-48.; Levesque D.A., Cummins C.O., Prochaska J.M., Prochaska J.O. Stage of change for making an informed decision about medicare health plans. Health Serv Res 2006;41:1372-91.; https://www.clinvest.ru/jour/article/view/19
Διαθεσιμότητα: https://www.clinvest.ru/jour/article/view/19